FAIRMOUNT FUNDS MANAGEMENT LLC purchased 6.8% of their position (150K shares) of ZENAS BIOPHARMA, INC. on the open market
Open‑market purchase worth $3.00M — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/1/2026ACC: 0001104659-26-038546
Director10% Owner
Since Sep 2024
+150K
Net shares
Net buyer
$3.00M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
150K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+150K
Price / share
$20.00
Trade value
$3M
% of position
6.8%
3/31/2026
2.21M→2.36M
Total
Net shares
+150K
Net value
$3M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/31/2026 | P · Purchase | +150K | $20.00 | $3M | 6.8% | 2.21M | 2.36M |
| Total | +150K | $3M | ||||||
Derivative Transactions0
No derivative transactions reported